<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
IVA
Inventiva
$
()


  • Inventiva announces LEGEND trial meets primary endpoint

    3/18/2024 - 16:51pm
  • Inventiva lifts pause on screening for NATiV3 clinical trial

    3/7/2024 - 17:09pm
  • Inventiva price target lowered by $2 at H.C. Wainwright, here's why

    2/20/2024 - 08:46am
  • Inventiva price target lowered by $12 at H.C. Wainwright, here's why

    12/21/2023 - 06:24am
  • Inventiva announces randomization of 1st patient in China in the NATiV3 trial

    12/20/2023 - 16:07pm
  • Roblox upgraded, Bristol Myers downgraded: Wall Street's top analyst calls

    10/27/2023 - 10:01am
  • Inventiva initiated with a Buy at Canaccord

    10/27/2023 - 06:38am
  • Inventiva enters licensing agreement with Hepalys, to receive $10M upfront

    9/21/2023 - 05:39am
  • B. Riley biotechnology analysts to hold an analyst/industry conference call

    7/10/2023 - 14:44pm
  • Fly Intel: Pre-market Movers

    6/14/2023 - 09:00am
  • Inventiva announces topline data from lanifibranor study

    6/13/2023 - 17:05pm
  • Inventiva initiated with a Buy at Roth MKM

    5/30/2023 - 16:36pm
  • Inventiva upgraded to Buy from Sell at Societe Generale

    5/19/2023 - 15:09pm
  • Inventiva price target lowered to $35 from $36 at H.C. Wainwright

    3/31/2023 - 06:17am
dynamic_feed Breaking News